Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y8JN
|
|||
Former ID |
DNC005048
|
|||
Drug Name |
2-(3-Methyl-indole-1-sulfonyl)-benzoic acid
|
|||
Synonyms |
CHEMBL361251; 2-(3-Methyl-indole-1-sulfonyl)-benzoic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H13NO4S
|
|||
Canonical SMILES |
CC1=CN(C2=CC=CC=C12)S(=O)(=O)C3=CC=CC=C3C(=O)O
|
|||
InChI |
1S/C16H13NO4S/c1-11-10-17(14-8-4-2-6-12(11)14)22(20,21)15-9-5-3-7-13(15)16(18)19/h2-10H,1H3,(H,18,19)
|
|||
InChIKey |
FBAOKNXTXGWCMO-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
KEGG Pathway | PPAR signaling pathway | |||
NetPath Pathway | TCR Signaling Pathway | |||
Pathway Interaction Database | AP-1 transcription factor network | |||
Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
Transcriptional regulation of white adipocyte differentiation | ||||
WikiPathways | Lipid digestion, mobilization, and transport | |||
Transcriptional Regulation of White Adipocyte Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.